Delays between a breast cancer diagnosis and treatment increase the risk of death for women with late-stage cancers, according to a recently published study. A second study found that the median wait time between diagnosis and treatment has grown longer.
New studies reveal important advances in cancer care quality measurement, physician adherence to quality standards, and end-of-life care, while highlighting the overuse of contralateral prophylactic mastectomy.
The ability to detect cancer DNA in the blood has been combined with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence, and find residual cancer left after surgery.
Surgical care provided to vulnerable population without increase in mortality, morbidity, costs.
The mTOR inhibitor dramatically reduced the volume of subependymal giant cell astrocytomas (SEGAs) in persons with tuberous sclerosis complex.
Persons with glioblastoma who undergo repeated resections can have improved survival, indicate the findings of a recent study.
A facility favoring early surgical resection of low-grade glioma had better overall survival rates than did a facility favoring watchful waiting.
Women who have surgery for ovarian cancer at high-volume hospitals have superior outcomes compared with similar patients at low-volume hospitals. This improved survival rate is dependent on the treatment of complications, and not on a lower rate of complications following surgery.
MALND, en endoscopic technique to determine if breast cancer has spread to the adjoining lymph nodes, can reduce the complications associated with the conventional surgical approach to axillary lymph node dissection.
The quality of breast cancer surgery improved when percutaneous needle biopsy was performed preoperatively.
